ALLARITY THERAPEUTICS INC (ALLR)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.42-0.70%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ALLR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | 0.3 | — | — | — | — | — |
| Gross Profit | — | — | — | — | (2.3) | — | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 5.5 | 6.6 | 6.1 | 7.1 | 6.9 | 14.2 | 4.2 |
| Operating Income | (10.8) | (12.6) | (27.2) | (17.1) | (34.5) | (26.6) | (8.3) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 0.2 | 0.7 | 0.5 | 0.2 | — | 0.1 |
| Interest & Investment Income | 0.7 | 0.8 | 0.5 | 0.0 | 0.0 | — | — |
| Net Interest Expenses | — | — | — | 0.5 | 0.2 | — | — |
| Other Non-Operating Income / Expenses | (1.5) | 1.4 | 2.3 | 5.3 | 16.9 | 0.0 | — |
| Asset Writedown | — | — | — | — | 3.6 | — | — |
| EBT, Incl. Unusual Items | — | (11.2) | (24.9) | (11.8) | (17.6) | — | — |
| Income Tax Expense | — | — | (0.4) | 0.1 | (1.5) | 0.1 | 0.2 |
| Net Income | |||||||
| Minority Interest | — | — | — | — | — | — | (0.0) |
| Net Income | (12.3) | (11.2) | (24.5) | (11.9) | (16.1) | (26.6) | (6.6) |
| Per Share | |||||||
| Basic EPS | (0.78) | (0.78) | (15.65) | — | — | (4.19) | (2.03) |
| Diluted EPS | — | — | — | (10.26) | — | (4.19) | — |
| Basic Weighted Avg Shares | 15.9 | 14.4 | 1.6 | 0.0 | 0.0 | 6.4 | 3.3 |
| Diluted Weighted Avg Shares | — | — | — | 2.0 | 0.0 | 6.4 | 3.3 |
| Supplemental | |||||||
| EBITDA | — | — | (27.2) | (17.1) | (34.4) | (26.5) | (8.3) |
| EBIT | (10.8) | (12.6) | (27.2) | (17.1) | (34.5) | (26.6) | (8.3) |
| Effective Tax Rate | — | — | — | -0.7% | 8.7% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.